Cover Image
市場調查報告書

腦損傷:全球臨床實驗趨勢

Brain Injury Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 239402
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
腦損傷:全球臨床實驗趨勢 Brain Injury Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月25日 內容資訊: 英文 87 Pages
簡介

本報告提供腦損傷臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 腦損傷
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦損傷的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦損傷的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

腦損傷治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • ZonMw
    • Novo A/S
    • Cato Research Ltd.
    • Canbex Therapeutics Ltd.
    • AstraZeneca Plc
    • Astellas Pharma Inc.
    • AmKor Pharma, Inc.
    • Alexander David Investments PLC (Inactive)
    • Actavis Plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • Vanderbilt University
    • ALYN Pediatric and Adolescent Rehabilitation Center
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Shaanxi Provincial People's Hospital
    • Tabriz University of Medical Sciences
    • University of Nottingham
    • Assistance Publique - Hopitaux de Paris
    • Associacao de Assistencia a Crianca Deficiente
    • Atlantic Health System
    • Baycrest

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2742CTIDB

GlobalData's clinical trial report, "Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Brain Injury
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Brain Injury to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Brain Injury
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Brain Injury Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • ZonMw
      • Clinical Trial Overview of ZonMw
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • Cato Research Ltd.
      • Clinical Trial Overview of Cato Research Ltd.
      • Canbex Therapeutics Ltd.
      • Clinical Trial Overview of Canbex Therapeutics Ltd.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • AmKor Pharma, Inc.
      • Clinical Trial Overview of AmKor Pharma, Inc.
      • Alexander David Investments PLC (Inactive)
      • Clinical Trial Overview of Alexander David Investments PLC (Inactive)
      • Actavis Plc
      • Clinical Trial Overview of Actavis Plc
    • Clinical Trial Overview of Top Institutes / Government
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • ALYN Pediatric and Adolescent Rehabilitation Center
      • Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Shaanxi Provincial People's Hospital
      • Clinical Trial Overview of Shaanxi Provincial People's Hospital
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • University of Nottingham
      • Clinical Trial Overview of University of Nottingham
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Associacao de Assistencia a Crianca Deficiente
      • Clinical Trial Overview of Associacao de Assistencia a Crianca Deficiente
      • Atlantic Health System
      • Clinical Trial Overview of Atlantic Health System
      • Baycrest
      • Clinical Trial Overview of Baycrest
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Brain Injury Therapeutics, Global, Clinical Trials by Region, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Brain Injury Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Brain Injury Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Brain Injury Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AmKor Pharma, Inc., 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexander David Investments PLC (Inactive), 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis Plc, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaanxi Provincial People's Hospital, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Associacao de Assistencia a Crianca Deficiente, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Atlantic Health System, 2015*
  • Brain Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Baycrest, 2015*

List of Figures

  • Brain Injury Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Brain Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Brain Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Brain Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Brain Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Brain Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Brain Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Brain Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Brain Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Brain Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Brain Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Brain Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Brain Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Brain Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top